Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect
- 1 March 2009
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 605 (1-3), 114-116
- https://doi.org/10.1016/j.ejphar.2009.01.002
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension testsJournal of Psychopharmacology, 2008
- Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidNeuropharmacology, 2007
- Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptorsBiochemical Pharmacology, 2007
- Nicotine receptor partial agonists for smoking cessationPublished by Wiley ,2007
- Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in miceBehavioural Brain Research, 2006
- METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRODrug Metabolism and Disposition, 2005
- Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking CessationJournal of Medicinal Chemistry, 2005
- High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferationBiological Psychiatry, 2004
- TC‐1734: An Orally Active Neuronal Nicotinic Acetylcholine Receptor Modulator with Antidepressant, Neuroprotective and Long‐Lasting Cognitive EffectsCNS Drug Reviews, 2004
- Nicotinic acetylcholine receptors as targets for antidepressantsMolecular Psychiatry, 2002